Study finds a marijuana derivative might reduce seizure frequency and may be safe for use in treatment-resistant epilepsy.
Adam Rifkin stashed this in Medicine
Stashed in: Marijuana
Our findings suggest that cannabidiol might reduce seizure frequency and might have an adequate safety profile in children and young adults with highly treatment-resistant epilepsy. Randomised controlled trials are warranted to characterise the safety profile and true efficacy of this compound.